Dr Reddys told to pay around Rs 339 crore to Hatchtech Medical Dialogues Team17 Jun 2021 1:00 PM ISTNew Delhi: Dr Reddy's Laboratories on Tuesday said it has been asked to pay USD 46.25 million (around Rs 339 crore) to Australia-based Hatchtech Pty...
DRDO invites Indian pharma firms for bulk production of COVID drug 2DG Medical Dialogues Team10 Jun 2021 6:26 PM ISTNew Delhi: The Defence Research and Development Organisation (DRDO) has called for an Expression of Interest (EoI) for Transfer of Technology (ToT)...
BMC in talks with Dr Reddys after rejecting all 9 vaccine supply bids Medical Dialogues Team7 Jun 2021 10:15 AM ISTMumbai: After rejecting all nine bids from facilitator firms for procurement of 1 crore Covid-19 vaccine doses for Mumbai due to insufficient...
NPPA directs Cipla, Sun Pharma, others to reduce Remdesivir MRP Medical Dialogues Team17 April 2021 4:13 PM ISTNew Delhi: With the demands of Covid-19 drug Remdesivir shooting up, the National Pharmaceutical Pricing Authority (NPPA) has directed drugmakers...
Dr Reddys Baddi unit gets Drug Controller nod to produce Remdesivir for domestic use Medical Dialogues Team14 April 2021 4:36 PM ISTBaddi: Drug major Dr Reddy's Laboratories' has recently secured permission from the Drug Controller to develop the antiviral Remdesivir, which is a...
Amlodipine, Telmisartan Combination better than Monotherapy: TEAMSTA 5 Study Dr. Prem Aggarwal13 April 2021 12:45 PM ISTThe hypertensive pressure continues to mount!Hypertension or high blood pressure (BP) affects 1.39 billion people worldwide. Nearly 25% men and...
Submit more data on Sputnik V: CDSCO panel to Dr Reddys Medical Dialogues Team11 April 2021 11:15 AM ISTNew Delhi: In response to an application for emergency use authorization of Russian Covid-19 vaccine Sputnik V, the Subject Expert Committee (SEC)...
Submit more immunogenicity, safety data on Sputnik V vaccine: CDSCO panel to Dr Reddys Ruchika Sharma25 Feb 2021 12:38 PM ISTOnce Dr Reddy's Labs submits the data, its Emergency Use Authorization application will be considered," a source said.
Dr Reddys launches generic equivalent of Xeloda in US Hina Zahid17 Feb 2021 10:00 AM ISTThe product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA), Dr...
Dr Reddys proposal for emergency use approval of Olokizumab for Covid-19 rejected by CDSCO panel MD Bureau2 Feb 2021 7:59 PM ISTNew Delhi: In a setback to Dr Reddy's Laboratories Limited, the Central Drugs Standard Control Organization (CDSCO) committee has rejected its...
Dr Reddys, Zuventus get CDSCO panel okay to conduct Covid-19 trials on Aviptadil Farhat Nasim27 Jan 2021 6:26 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to Dr...
Hub for vaccine developers, Hyderabad to hold special significance in 2021 Ruchika Sharma28 Dec 2020 2:40 PM ISTHyderabad: As the world is set to brace for a new year amid the Covid-19 pandemic, the city is poised to emerge as a 'saviour' from the killer virus,...
